市場調查報告書
商品編碼
1067811

肺部藥物輸送系統的全球市場-產業分析,市場規模,佔有率,成長,趨勢,預測(2022年∼2028年)

Global Pulmonary Drug Delivery Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球肺部藥物輸送系統市場相關調查分析,提供產業分析,市場分析,競爭情形,企業簡介等系統性資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 肺部藥物輸送系統-產業分析

  • 簡介-市場動態
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 產業趨勢
  • 波特的五力分析
  • 市場魅力分析

第4章 價值鏈分析

  • 價值鏈分析
  • 原料分析
  • 潛在的買主的清單
  • 行銷流通管道

第5章 COVID-19疫情的影響分析

  • COVID-19疫情的影響分析
  • COVID-19影響分析:生產,進口,出口及各需求
  • 市場:COVID-19以前 vs COVID-19以後
  • 冠狀病毒(COVID-19)疫情的影響估計
  • COVID-19:微觀及宏觀因素分析

第6章 全球肺部藥物輸送系統市場分析:各產品

  • 概要:各產品
  • 實際成果資料與預測資料
  • 分析:各產品
  • 乾粉吸入劑的銷售業績及預測:各地區
  • 定量吸入器的銷售業績及預測:各地區
  • 噴霧器的銷售業績及預測:各地區

第7章 全球肺部藥物輸送系統市場分析:各應用領域

  • 概要:各應用領域
  • 實際成果資料與預測資料
  • 分析:各應用領域
  • 氣喘的銷售業績及預測:各地區
  • 慢性阻塞性肺病(COPD)的銷售業績及預測:各地區
  • 囊狀纖維化症的銷售業績及預測:各地區
  • 其他的銷售業績及預測:各地區

第8章 全球肺部藥物輸送系統市場分析:各流通管道

  • 概要:各流通管道
  • 實際成果資料與預測資料
  • 分析:各流通管道
  • 零售藥局的銷售業績及預測:各地區
  • 醫院藥局的銷售業績及預測:各地區
  • 電子商務的銷售業績及預測:各地區

第9章 全球肺部藥物輸送系統市場分析:各地區

  • 地區展望銷售分析
  • 簡介銷售分析
  • 北美的銷售分析
  • 歐洲的銷售分析
  • 亞太地區的銷售分析
  • 南美的銷售分析
  • 中東·非洲的銷售分析

第10章 肺部藥物輸送系統企業的競爭情形

  • 肺部藥物輸送系統市場上競爭
  • 夥伴關係/合作/契約
  • 合併和收購
  • 新產品的銷售
  • 其他的開發

第11章 企業簡介

  • 主要企業的市場佔有率分析
  • 市場集中度
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Koninklijke Philips NV
  • 3M Company
  • Actelion Pharmaceuticals Ltd.(Janssen)
  • Clement
  • Clarke International
  • Briggs Healthcare
  • Aerogen

注:財務細節和公司概況的最新發展需該公司予以公開。可能不包含私人公司在內。

目錄
Product Code: VMR11217544

Value Market Research deeply researched the Global Pulmonary Drug Delivery Systems Market to foresee a significant growth in the industry over the upcoming years. The global pulmonary drug delivery systems market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global pulmonary drug delivery systems market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this pulmonary drug delivery systems market.

The next sections of the pulmonary drug delivery systems market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Product

Dry Powder Inhaler (Single Dose Inhaler, Multi Dose Inhaler)

Metered Dose Inhaler (Manually-Actuated Pressurized Inhaler, Breath-Actuated Pressurized Inhaler)

Nebulizer (Jet Nebulizer, Ultrasonic Wave Nebulizer, Vibrating Mesh Nebulizer)

By Application

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis

Others

By Distribution Channel

Retail Pharmacies

Hospital Pharmacies

E-commerce

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PULMONARY DRUG DELIVERY SYSTEMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Dry Powder Inhaler Historic and Forecast Sales by Regions
  • 6.5 Metered Dose Inhaler Historic and Forecast Sales by Regions
  • 6.6 Nebulizer Historic and Forecast Sales by Regions

7 . GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Asthma Historic and Forecast Sales by Regions
  • 7.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
  • 7.6 Cystic Fibrosis Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.6 E-commerce Historic and Forecast Sales by Regions

9 . GLOBAL PULMONARY DRUG DELIVERY SYSTEMS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PULMONARY DRUG DELIVERY SYSTEMS COMPANIES

  • 10.1. Pulmonary Drug Delivery Systems Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF PULMONARY DRUG DELIVERY SYSTEMS INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. AstraZeneca Plc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Boehringer Ingelheim GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. GlaxoSmithKline plc
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Novartis AG
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Koninklijke Philips N.V.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. 3M Company
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Actelion Pharmaceuticals Ltd. (Janssen)
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Clement
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Clarke International
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Briggs Healthcare
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Aerogen
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Dry Powder Inhaler Market Sales by Geography (USD MN)
  • Metered Dose Inhaler Market Sales by Geography (USD MN)
  • Nebulizer Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Chronic Obstructive Pulmonary Disease (COPD) Market Sales by Geography (USD MN)
  • Cystic Fibrosis Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • E-commerce Market Sales by Geography (USD MN)
  • Global Pulmonary Drug Delivery Systems Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Pulmonary Drug Delivery Systems Report
  • Market Research Process
  • Market Research Methodology
  • Global Pulmonary Drug Delivery Systems Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Dry Powder Inhaler Market Sales by Geography (USD MN)
  • Metered Dose Inhaler Market Sales by Geography (USD MN)
  • Nebulizer Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Asthma Market Sales by Geography (USD MN)
  • Chronic Obstructive Pulmonary Disease (COPD) Market Sales by Geography (USD MN)
  • Cystic Fibrosis Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • E-commerce Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top 10 Company Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.